JP2009037588A - 糖尿病の管理用プログラム - Google Patents
糖尿病の管理用プログラム Download PDFInfo
- Publication number
- JP2009037588A JP2009037588A JP2008063000A JP2008063000A JP2009037588A JP 2009037588 A JP2009037588 A JP 2009037588A JP 2008063000 A JP2008063000 A JP 2008063000A JP 2008063000 A JP2008063000 A JP 2008063000A JP 2009037588 A JP2009037588 A JP 2009037588A
- Authority
- JP
- Japan
- Prior art keywords
- hypoglycemia
- hyperglycemia
- occurrence
- day
- blood glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 56
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 390
- 239000008103 glucose Substances 0.000 claims abstract description 390
- 239000008280 blood Substances 0.000 claims abstract description 203
- 210000004369 blood Anatomy 0.000 claims abstract description 203
- 238000004590 computer program Methods 0.000 claims abstract description 35
- 230000002641 glycemic effect Effects 0.000 claims abstract description 15
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 219
- 201000001421 hyperglycemia Diseases 0.000 claims description 198
- 208000013016 Hypoglycemia Diseases 0.000 claims description 194
- 238000005259 measurement Methods 0.000 claims description 182
- 238000012360 testing method Methods 0.000 claims description 154
- 235000012054 meals Nutrition 0.000 claims description 116
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 90
- 102000004877 Insulin Human genes 0.000 claims description 45
- 108090001061 Insulin Proteins 0.000 claims description 45
- 229940125396 insulin Drugs 0.000 claims description 45
- 238000004364 calculation method Methods 0.000 claims description 19
- 230000000291 postprandial effect Effects 0.000 claims description 17
- 230000003345 hyperglycaemic effect Effects 0.000 claims description 13
- 230000008859 change Effects 0.000 claims description 9
- 238000010835 comparative analysis Methods 0.000 claims description 5
- 230000002596 correlated effect Effects 0.000 claims 3
- 238000000034 method Methods 0.000 description 68
- 238000007726 management method Methods 0.000 description 34
- 230000008569 process Effects 0.000 description 20
- 238000000546 chi-square test Methods 0.000 description 14
- 238000003909 pattern recognition Methods 0.000 description 13
- 235000005911 diet Nutrition 0.000 description 12
- 230000000378 dietary effect Effects 0.000 description 12
- 238000000528 statistical test Methods 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 6
- 238000004891 communication Methods 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 5
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000003442 weekly effect Effects 0.000 description 4
- 235000021152 breakfast Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 238000001367 Mood's median test Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 235000021074 carbohydrate intake Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 238000001151 non-parametric statistical test Methods 0.000 description 2
- 230000001019 normoglycemic effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- COBBNRKBTCBWQP-UHFFFAOYSA-N Graveoline Chemical compound C1=C2OCOC2=CC(C=2N(C3=CC=CC=C3C(=O)C=2)C)=C1 COBBNRKBTCBWQP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000013523 data management Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- -1 for example Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 229940127560 insulin pen Drugs 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
- A61B5/7435—Displaying user selection data, e.g. icons in a graphical user interface
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00722—Communications; Identification
- G01N35/00871—Communications between instruments or with remote terminals
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Primary Health Care (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Human Computer Interaction (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- External Artificial Organs (AREA)
Abstract
【解決手段】ユーザに糖尿病の管理情報を提供するためのコンピュータプログラムは、ユーザインターフェイスと、患者の血糖に関する複数のデータインプットを有するデータベースモジュールと、このデータベースモジュールと通信するビジネスオブジェクトモジュールと、データベースモジュールとビジネスオブジェクトモジュールに基づき、複数のテキストメッセージをユーザインターフェイスに発信する糖尿病管理ルールエンジンと、を備える。前記テキストメッセージは、1日の時間、週の曜日、1日の時間及び週の曜日の双方、又は異なる時間間隔の少なくとも1つで、少なくとも過度の変動を示す患者データからの統計的に有意なパターンを含む。
【選択図】なし
Description
Claims (25)
- ユーザに糖尿病の管理情報を提供するためのコンピュータプログラムであって、
ユーザインターフェイスと、患者の血糖に関する複数のデータインプットを有するデータベースモジュールと、このデータベースモジュールと通信するビジネスオブジェクトモジュールと、データベースモジュールとビジネスオブジェクトモジュールに基づき、複数のテキストメッセージをユーザインターフェイスに発信する糖尿病管理ルールエンジンと、を備え、
前記テキストメッセージは、1日の時間、週の曜日、1日の時間及び週の曜日の双方、又は異なる時間間隔の少なくとも1つで、少なくとも過度の変動を示す患者データからの統計的に有意なパターンを含むコンピュータプログラム。 - 前記テキストメッセージは、(a)低血糖症の発生、(b)高血糖症の発生、(c)過剰修正、(d)夜間の血糖濃度と昼間の血糖濃度の間の相違、及び(e)ある時間枠について又はいろいろな時間枠での患者の糖血症状態の比較分析の少なくとも1つの表示を含む請求項1記載のコンピュータプログラム。
- 前記低血糖症の発生は、(i)時間枠による低血糖症の発生、(ii)週の曜日による低血糖症の発生、(iii)食前の低血糖症の発生、及び(iv)食後の低血糖症の発生を含む請求項2記載のコンピュータプログラム。
- 前記低血糖症の発生は、所定時間内の低血糖発症の計算割合を含む低血糖症発生のテキスト表示であって、前記計算割合が5%を超えるときは常に提示されるテキスト表示、又は
計算割合が100%のときは常に提示される、全グルコース測定値が低血糖症であるとのテキスト表示を含み、
これら以外の場合には、低血糖症発生のテキスト表示は提示されない請求項2記載のコンピュータプログラム。 - テキストメッセージは、時間帯と低血糖発症との間で統計上の相関関係が決定され、低血糖症発生のテキスト表示があるときは常に提示される、特定の時間枠における高めの低血糖症の表示を含む請求項4記載のコンピュータプログラム。
- テキストメッセージは、週の曜日と低血糖発症との間で統計上の相関関係が決定され、低血糖症発生のテキスト表示があるときは常に提示される、週の特定日における高めの低血糖症の表示を含む請求項4記載のコンピュータプログラム。
- テキストメッセージは、所定時間内での食前グルコース測定値としてマークされた食前グルコース測定値が5%を超えるときは常に提示される、食前の低血糖発症の発生又は頻度の表示を含む請求項2記載のコンピュータプログラム。
- テキストメッセージは、所定時間内での食後グルコース測定値としてマークされたグルコース測定値が約5%を超えるときは常に提示される、食後の低血糖発症の表示を含む請求項2記載のコンピュータプログラム。
- 低血糖症の発生は、(i)時間枠による高血糖症の発生、(ii)週の曜日による高血糖症の発生、(iii)食前の高血糖症の発生、及び(iv)食後の高血糖症の発生を含む請求項2記載のコンピュータプログラム。
- 高血糖症の発生は、所定の時間内の高血糖発症の計算割合を含む高血糖症発生のテキスト表示であって、前記計算割合が約15%を超えるときは常に提示されるテキスト表示、又は
計算割合が100%のときは常に提示され、全グルコース測定値が高血糖症であるとのテキスト表示を含み、
これら以外の場合には、高血糖症発生のテキスト指示が提示されない請求項9記載のコンピュータプログラム。 - テキストメッセージは、時間帯と高血糖発症との間で統計上の相関関係が決定され、高血糖症発生のテキスト指示があれば常に提示される、特定の時間内の高めの高血糖症の表示を含む請求項10記載のコンピュータプログラム。
- テキストメッセージは、週の曜日と高血糖発症との間で統計上の相関関係が決定され、高血糖症発生のテキスト指示があれば常に、週の特定日における高めの高血糖症の指示の請求項10記載のコンピュータプログラム。
- テキストメッセージは、所定時間内での食前血糖測定値としてマークされた食前血糖測定値が約5%を超えるときは常に提示される、食前の高血糖発症のテキスト表示が請求項9記載のコンピュータプログラム。
- テキストメッセージは、所定の時間内で、食後血糖測定値としてマークされた約5%を超える血糖測定値があれば常に提示される、食後の高血糖発症のテキスト表示を含む請求項9記載のコンピュータプログラム。
- 変動は、(i)全体の変動、(ii)低血糖症の高血糖症リバウンド、及び(iii)高血糖症から低血糖症への発生を含む請求項2記載のコンピュータプログラム。
- テキストメッセージは、所定時間内の患者の計算血糖変動が、1デシリットルあたり90ミリグラム又はそれよりも大きいときは常に提示される、高い血糖変動を示す表示を含む請求項15記載のコンピュータプログラム。
- テキストメッセージは、4時間未満の所定時間内で、高血糖発症から低血糖発症への変化があれば常に提示される、低血糖症の高血糖症リバウンドへの可能性を示す表示を含む請求項15記載のコンピュータプログラム。
- テキストメッセージは、4時間未満の所定時間内で、低血糖発症から高血糖発症への変化があれば常に提示される、高血糖症の低血糖症リバウンドを示す表示を含む請求項15記載のコンピュータプログラム。
- 前記相違は、計算された相違が50mg/dLよりも大きいときに提示される、報告期間内の食前と食後との中央値間の計算された相違のテキスト表示を含む請求項2記載のコンピュータプログラム。
- 低糖血症状態の前記比較分析は、2つ又はそれ以上の時間枠での低血糖症の測定数と、全時間枠についての血糖の全測定数とに基づき、上向きの低血糖症動向又は下向きの低血糖症動向の1つのテキスト表示を含む請求項2記載のコンピュータプログラム。
- 高糖血症状態の前記比較分析は、2つ又はそれ以上の時間枠での低血糖症の測定数と、全時間枠についての血糖の全測定数とに基づき、上向きの低血糖症動向又は下向きの低血糖症動向の1つのテキスト表示を含む請求項2記載のコンピュータプログラム。
- 糖尿病管理ルールエンジンは、(a)一時的期間内の血糖濃度値の中央値と、(b)前記一時的期間内のテスト時間の中央値とを関連付け、血糖値及びテスト時間を有する二次元座標グラフ上にデータ点を定める請求項1記載のコンピュータプログラム。
- 前記糖尿病管理ルールエンジンは、(i)一時的期間の全体のインスリン用量の中央値と、(ii)前記一時的期間内の投与時間の中央値とを関連付け、インスリン用量及び投与時間を有する二次元座標グラフ上にデータ点を定める請求項22記載のコンピュータプログラム。
- 前記一時的期間は、1日の特定の時間枠、1日の複数の時間枠、週の特定日、又は週の複数の特定日の少なくとも1つを含む請求項23記載のコンピュータプログラム。
- 前記一時的期間は、1日内の特定の時間枠における食前テストを有するテスト発生、週の特定日における食前テストを有するテスト発生、週の複数特定日における食前テストを有するテスト発生、1日内の特定時間枠における食後テストを有するテスト発生、週の特定日における食後テストを有するテスト発生、又は週の複数特定日における食後テストを有するテスト発生の少なくとも1つを含む請求項24記載のコンピュータプログラム。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/688,743 US20080234943A1 (en) | 2007-03-20 | 2007-03-20 | Computer program for diabetes management |
US11/688,743 | 2007-03-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009037588A true JP2009037588A (ja) | 2009-02-19 |
JP5179906B2 JP5179906B2 (ja) | 2013-04-10 |
Family
ID=39534913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008063000A Active JP5179906B2 (ja) | 2007-03-20 | 2008-03-12 | 糖尿病の管理用プログラム |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080234943A1 (ja) |
EP (1) | EP1988482A3 (ja) |
JP (1) | JP5179906B2 (ja) |
CN (1) | CN101308528A (ja) |
CA (1) | CA2627385A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013520278A (ja) * | 2010-02-25 | 2013-06-06 | ライフスキャン・スコットランド・リミテッド | 高血糖及び低血糖傾向を通知する分析物試験方法及びシステム |
JP2013533783A (ja) * | 2010-06-30 | 2013-08-29 | ライフスキャン・スコットランド・リミテッド | 平均の食事前と食事後のグルコース差のメッセージ表示について統計的検出力を確実にするための方法、システム、及び装置 |
US8974385B2 (en) | 2009-09-23 | 2015-03-10 | Samsung Electronics Co., Ltd. | Method and apparatus for providing blood glucose management information |
JP2019509085A (ja) * | 2016-02-05 | 2019-04-04 | アニマス・コーポレイション | 薬物送達システムのための可視化及び解析ツール |
JP2019532391A (ja) * | 2016-08-17 | 2019-11-07 | ノボ・ノルデイスク・エー/エス | インスリン投薬計画における基礎/ボーラス比を調節するためのシステムおよび方法 |
JP2020507397A (ja) * | 2017-02-14 | 2020-03-12 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | 体液中のグルコースレベルを示すグルコースモニタリングデータを分析するための、コンピュータにより実施される方法および携帯型装置、ならびにコンピュータプログラム製品 |
WO2020111109A1 (ja) * | 2018-11-27 | 2020-06-04 | 国立研究開発法人理化学研究所 | 状態可視化装置、状態可視化方法および状態可視化プログラム |
Families Citing this family (156)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003303597A1 (en) | 2002-12-31 | 2004-07-29 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
CA2556331A1 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
CN101365374B (zh) | 2005-08-31 | 2011-11-16 | 弗吉尼亚大学专利基金委员会 | 改善连续式葡萄糖传感器的准确度 |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
US8224415B2 (en) | 2009-01-29 | 2012-07-17 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US7630748B2 (en) | 2006-10-25 | 2009-12-08 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US8932216B2 (en) | 2006-08-07 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US8206296B2 (en) | 2006-08-07 | 2012-06-26 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
CA2667639A1 (en) | 2006-10-26 | 2008-05-02 | Abbott Diabetes Care Inc. | Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors |
US20080199894A1 (en) | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US8758245B2 (en) * | 2007-03-20 | 2014-06-24 | Lifescan, Inc. | Systems and methods for pattern recognition in diabetes management |
US20080235053A1 (en) * | 2007-03-20 | 2008-09-25 | Pinaki Ray | Communication medium for diabetes management |
US9615780B2 (en) | 2007-04-14 | 2017-04-11 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
US9204827B2 (en) | 2007-04-14 | 2015-12-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
CA2683863C (en) | 2007-04-14 | 2019-01-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
CA2683721C (en) | 2007-04-14 | 2017-05-23 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
WO2008130898A1 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
EP2535830B1 (en) | 2007-05-30 | 2018-11-21 | Ascensia Diabetes Care Holdings AG | Method and system for managing health data |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
US20090143725A1 (en) * | 2007-08-31 | 2009-06-04 | Abbott Diabetes Care, Inc. | Method of Optimizing Efficacy of Therapeutic Agent |
US7998069B2 (en) * | 2007-09-11 | 2011-08-16 | Roche Diagnostics Operations, Inc. | Mask algorithms for health management systems |
US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
US8409093B2 (en) | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
US9220456B2 (en) | 2008-04-04 | 2015-12-29 | Hygieia, Inc. | Systems, methods and devices for achieving glycemic balance |
CN103400028B (zh) * | 2008-04-04 | 2017-04-12 | 海吉雅有限公司 | 用于优化患者的胰岛素剂量方案的装置 |
US10624577B2 (en) | 2008-04-04 | 2020-04-21 | Hygieia, Inc. | Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus |
EP2276405A4 (en) * | 2008-05-12 | 2013-10-09 | Us Dept Veterans Affairs | AUTOMATED SYSTEM AND METHOD FOR DIABETES CONTROL |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US9943644B2 (en) | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
US20100057040A1 (en) | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
US9149220B2 (en) | 2011-04-15 | 2015-10-06 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
WO2010056718A2 (en) | 2008-11-11 | 2010-05-20 | Hygieia, Inc. | Apparatus and system for diabetes management |
US10456036B2 (en) | 2008-12-23 | 2019-10-29 | Roche Diabetes Care, Inc. | Structured tailoring |
KR101285520B1 (ko) * | 2008-12-23 | 2013-07-17 | 에프. 호프만-라 로슈 아게 | 만성 질병을 가진 환자의 진단 또는 치료 지원을 위한 구조화된 테스팅 방법 및 그 디바이스 |
US9117015B2 (en) | 2008-12-23 | 2015-08-25 | Roche Diagnostics Operations, Inc. | Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device |
US8849458B2 (en) | 2008-12-23 | 2014-09-30 | Roche Diagnostics Operations, Inc. | Collection device with selective display of test results, method and computer program product thereof |
US9918635B2 (en) | 2008-12-23 | 2018-03-20 | Roche Diabetes Care, Inc. | Systems and methods for optimizing insulin dosage |
US20120011125A1 (en) | 2008-12-23 | 2012-01-12 | Roche Diagnostics Operations, Inc. | Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device |
US10437962B2 (en) | 2008-12-23 | 2019-10-08 | Roche Diabetes Care Inc | Status reporting of a structured collection procedure |
US20100160740A1 (en) * | 2008-12-24 | 2010-06-24 | Gary Cohen | Use of Patterns in a Therapy Management System |
US9330237B2 (en) * | 2008-12-24 | 2016-05-03 | Medtronic Minimed, Inc. | Pattern recognition and filtering in a therapy management system |
US20100174553A1 (en) * | 2008-12-24 | 2010-07-08 | Medtronic Minimed, Inc. | Diabetes Therapy Management System |
CN101789229B (zh) * | 2009-01-23 | 2015-03-11 | 理康互联科技(北京)有限公司 | 健康信息显示控制的装置、方法及对应设备和试剂载体 |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
ES2654592T3 (es) | 2009-03-30 | 2018-02-14 | F. Hoffmann-La Roche Ag | Procedimiento y sistema para la determinación de la diferencia entre valores de glucemia preprandiales y posprandiales |
WO2010121084A1 (en) | 2009-04-15 | 2010-10-21 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US8483967B2 (en) | 2009-04-29 | 2013-07-09 | Abbott Diabetes Care Inc. | Method and system for providing real time analyte sensor calibration with retrospective backfill |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
CN102483775A (zh) * | 2009-06-30 | 2012-05-30 | 生命扫描有限公司 | 被分析物测试方法和系统 |
FI20095791A0 (fi) | 2009-07-15 | 2009-07-15 | Ihq Medical Inc | Menetelmä ja järjestely mittauksen kontrolloimiseksi |
CN102469966B (zh) | 2009-07-23 | 2015-05-13 | 雅培糖尿病护理公司 | 持续分析物测量系统和用于植入它们的系统和方法 |
DK3173014T3 (da) | 2009-07-23 | 2021-09-13 | Abbott Diabetes Care Inc | Realtidsstyring af data vedrørende fysiologisk kontrol af glucoseniveauer |
WO2011014851A1 (en) | 2009-07-31 | 2011-02-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
DK3718922T3 (da) | 2009-08-31 | 2022-04-19 | Abbott Diabetes Care Inc | Glucoseovervågningssystem og fremgangsmåde |
EP2473099A4 (en) | 2009-08-31 | 2015-01-14 | Abbott Diabetes Care Inc | ANALYTICAL SUBSTANCE MONITORING SYSTEM AND METHODS OF MANAGING ENERGY AND NOISE |
US9265429B2 (en) * | 2009-09-18 | 2016-02-23 | Welch Allyn, Inc. | Physiological parameter measuring platform device supporting multiple workflows |
EP2482720A4 (en) | 2009-09-29 | 2014-04-23 | Abbott Diabetes Care Inc | METHOD AND APPARATUS FOR PROVIDING NOTIFICATION FUNCTION IN SUBSTANCE MONITORING SYSTEMS |
US8185181B2 (en) | 2009-10-30 | 2012-05-22 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
CA2728831A1 (en) * | 2010-01-22 | 2011-07-22 | Lifescan, Inc. | Diabetes management unit, method, and system |
US20110208027A1 (en) * | 2010-02-23 | 2011-08-25 | Roche Diagnostics Operations, Inc. | Methods And Systems For Providing Therapeutic Guidelines To A Person Having Diabetes |
WO2011112753A1 (en) | 2010-03-10 | 2011-09-15 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US8532933B2 (en) | 2010-06-18 | 2013-09-10 | Roche Diagnostics Operations, Inc. | Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
KR101889575B1 (ko) * | 2010-11-05 | 2018-08-17 | 시노케어 메디텍, 인크. | 당뇨병의 검출을 위한 개선된 알고리즘 |
US20120173151A1 (en) | 2010-12-29 | 2012-07-05 | Roche Diagnostics Operations, Inc. | Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US9619625B2 (en) | 2011-03-30 | 2017-04-11 | Novo Nordisk A/S | System for optimizing a patient's drug dosage regimen over time |
US8766803B2 (en) | 2011-05-13 | 2014-07-01 | Roche Diagnostics Operations, Inc. | Dynamic data collection |
US10448869B2 (en) | 2011-05-13 | 2019-10-22 | Roche Diabetes Care, Inc. | User-defined structured testing for use in diabetes care |
US8755938B2 (en) | 2011-05-13 | 2014-06-17 | Roche Diagnostics Operations, Inc. | Systems and methods for handling unacceptable values in structured collection protocols |
US20130085349A1 (en) | 2011-06-21 | 2013-04-04 | Yofimeter, Llc | Analyte testing devices |
US9622691B2 (en) | 2011-10-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
WO2013078426A2 (en) | 2011-11-25 | 2013-05-30 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
US9259190B2 (en) | 2011-12-29 | 2016-02-16 | Roche Diabetes Care, Inc. | Reminder management for manual entry diabetes application |
US20130172688A1 (en) * | 2011-12-29 | 2013-07-04 | Roche Diagnostics Operations, Inc. | Diabetes management application for mobile phone |
US20140012118A1 (en) * | 2012-07-09 | 2014-01-09 | Dexcom, Inc. | Systems and methods for leveraging smartphone features in continuous glucose monitoring |
EP2890297B1 (en) | 2012-08-30 | 2018-04-11 | Abbott Diabetes Care, Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
US9504412B2 (en) | 2012-09-17 | 2016-11-29 | Lifescan, Inc. | Method and system to derive glycemic patterns from clustering of glucose data |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
WO2014052136A1 (en) | 2012-09-26 | 2014-04-03 | Abbott Diabetes Care Inc. | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US8844057B2 (en) * | 2012-10-01 | 2014-09-23 | Dexcom, Inc. | Analyte data retriever |
US10383580B2 (en) | 2012-12-31 | 2019-08-20 | Abbott Diabetes Care Inc. | Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance |
US9351670B2 (en) | 2012-12-31 | 2016-05-31 | Abbott Diabetes Care Inc. | Glycemic risk determination based on variability of glucose levels |
CN105050539B (zh) * | 2013-01-14 | 2018-05-18 | 加利福尼亚大学董事会 | 用于1型糖尿病应用的人造胰腺的模型预测控制问题中的每日周期性目标区间调节 |
US10102344B2 (en) * | 2013-03-14 | 2018-10-16 | Roche Diabetes Care, Inc. | System and methods for analyzing blood glucose data and quantifying the success or failure of insulin therapy |
AU2014233094B2 (en) | 2013-03-15 | 2020-07-02 | Abbott Diabetes Care Inc. | System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk |
WO2014152034A1 (en) | 2013-03-15 | 2014-09-25 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US9965587B2 (en) | 2013-07-08 | 2018-05-08 | Roche Diabetes Care, Inc. | Reminder, classification, and pattern identification systems and methods for handheld diabetes management devices |
WO2015102745A1 (en) | 2013-12-31 | 2015-07-09 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
US9233204B2 (en) | 2014-01-31 | 2016-01-12 | Aseko, Inc. | Insulin management |
WO2015153482A1 (en) | 2014-03-30 | 2015-10-08 | Abbott Diabetes Care Inc. | Method and apparatus for determining meal start and peak events in analyte monitoring systems |
US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
EP3050023B1 (en) | 2014-10-27 | 2021-08-25 | Aseko, Inc. | Subcutaneous outpatient management |
WO2017011346A1 (en) | 2015-07-10 | 2017-01-19 | Abbott Diabetes Care Inc. | System, device and method of dynamic glucose profile response to physiological parameters |
CA2993275C (en) | 2015-08-20 | 2022-06-21 | Aseko, Inc. | Diabetes management therapy advisor |
US10867012B2 (en) * | 2015-08-21 | 2020-12-15 | Medtronic Minimed, Inc. | Data analytics and insight delivery for the management and control of diabetes |
WO2017166292A1 (zh) * | 2016-04-01 | 2017-10-05 | 创新精密仪器有限公司 | 一种可携式药物管理装置 |
US11062798B2 (en) * | 2016-06-07 | 2021-07-13 | Aseko, Inc. | Managing insulin administration |
JP2019530489A (ja) | 2016-08-17 | 2019-10-24 | ノボ・ノルデイスク・エー/エス | 食事イベントに関連したボーラスタイミングを最適化するためのシステムおよび方法 |
CN106618593A (zh) * | 2016-11-11 | 2017-05-10 | 深圳市元征软件开发有限公司 | 一种无创血糖设备自报警方法及无创血糖设备 |
CN108335750B (zh) * | 2017-01-20 | 2022-08-09 | 华广生技股份有限公司 | 动态分析血糖值的方法、系统与计算机存储介质 |
EP3600014A4 (en) | 2017-03-21 | 2020-10-21 | Abbott Diabetes Care Inc. | METHODS, DEVICES AND SYSTEM FOR PROVIDING DIAGNOSIS AND THERAPY FOR DIABETIC CONDITION |
USD853583S1 (en) | 2017-03-29 | 2019-07-09 | Becton, Dickinson And Company | Hand-held device housing |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US11943876B2 (en) | 2017-10-24 | 2024-03-26 | Dexcom, Inc. | Pre-connected analyte sensors |
JP2021501412A (ja) * | 2017-10-26 | 2021-01-14 | ベックマン コールター, インコーポレイテッド | 実験室器具のためのルールの自動生成 |
JP6923426B2 (ja) * | 2017-11-30 | 2021-08-18 | パラマウントベッド株式会社 | 異常判定装置及びそれに用いるプログラム |
CN113226156A (zh) * | 2018-10-15 | 2021-08-06 | 珀迪迈垂克斯公司 | 同侧溃疡和溃疡前期检测方法和设备 |
US11823783B2 (en) * | 2019-06-19 | 2023-11-21 | Dexcom, Inc. | Dynamic equivalent on board estimator |
CN112582072A (zh) * | 2020-12-23 | 2021-03-30 | 中南大学湘雅医院 | 一种住院患者血糖管理质量分析平台 |
US11857303B2 (en) | 2021-12-06 | 2024-01-02 | Podimetrics, Inc. | Apparatus and method of measuring blood flow in the foot |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002132952A (ja) * | 2000-04-28 | 2002-05-10 | Bryan K Chan | 慢性病と健康のオンラインを管理する方法及びシステム |
JP2004024699A (ja) * | 2002-06-27 | 2004-01-29 | Asahi Medical Co Ltd | 血糖管理システム、血糖管理プログラム、装着システムおよび血糖管理方法 |
JP2004154547A (ja) * | 2002-06-05 | 2004-06-03 | Diabetes Diagnostics Inc | 特定成分検査装置、データ格納方法およびデータ処理方法 |
WO2005093629A2 (en) * | 2004-03-26 | 2005-10-06 | Novo Nordisk A/S | Device for displaying data relevant for a diabetic patient |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6125525A (ja) * | 1984-07-13 | 1986-02-04 | 住友電気工業株式会社 | 患者監視装置 |
US4695954A (en) * | 1984-10-31 | 1987-09-22 | Rose Robert J | Modular medication dispensing system and apparatus utilizing portable memory device |
US4731726A (en) * | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
EP0290683A3 (en) * | 1987-05-01 | 1988-12-14 | Diva Medical Systems B.V. | Diabetes management system and apparatus |
US5216597A (en) * | 1987-05-01 | 1993-06-01 | Diva Medical Systems Bv | Diabetes therapy management system, apparatus and method |
US4817044A (en) * | 1987-06-01 | 1989-03-28 | Ogren David A | Collection and reporting system for medical appliances |
US5025374A (en) * | 1987-12-09 | 1991-06-18 | Arch Development Corp. | Portable system for choosing pre-operative patient test |
JPH06501858A (ja) * | 1990-08-31 | 1994-03-03 | ザ ジェネラル ホスピタル コーポレーション | ポータブル患者モニター装置のためのネットワーク(回路網) |
US5251126A (en) * | 1990-10-29 | 1993-10-05 | Miles Inc. | Diabetes data analysis and interpretation method |
US5376070A (en) * | 1992-09-29 | 1994-12-27 | Minimed Inc. | Data transfer system for an infusion pump |
US5997476A (en) * | 1997-03-28 | 1999-12-07 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US5956501A (en) * | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
US5307263A (en) * | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US5590648A (en) * | 1992-11-30 | 1997-01-07 | Tremont Medical | Personal health care system |
FI95427C (fi) * | 1992-12-23 | 1996-01-25 | Instrumentarium Oy | Tiedonsiirtojärjestelmä |
US6022315A (en) * | 1993-12-29 | 2000-02-08 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including network access |
US6206829B1 (en) * | 1996-07-12 | 2001-03-27 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including network access |
US5536249A (en) * | 1994-03-09 | 1996-07-16 | Visionary Medical Products, Inc. | Pen-type injector with a microprocessor and blood characteristic monitor |
US5704366A (en) * | 1994-05-23 | 1998-01-06 | Enact Health Management Systems | System for monitoring and reporting medical measurements |
US5946659A (en) * | 1995-02-28 | 1999-08-31 | Clinicomp International, Inc. | System and method for notification and access of patient care information being simultaneously entered |
US5713856A (en) * | 1995-03-13 | 1998-02-03 | Alaris Medical Systems, Inc. | Modular patient care system |
US6671563B1 (en) * | 1995-05-15 | 2003-12-30 | Alaris Medical Systems, Inc. | System and method for collecting data and managing patient care |
US5974389A (en) * | 1996-03-01 | 1999-10-26 | Clark; Melanie Ann | Medical record management system and process with improved workflow features |
US5878384A (en) * | 1996-03-29 | 1999-03-02 | At&T Corp | System and method for monitoring information flow and performing data collection |
US5959529A (en) * | 1997-03-07 | 1999-09-28 | Kail, Iv; Karl A. | Reprogrammable remote sensor monitoring system |
AU762361B2 (en) * | 1997-03-13 | 2003-06-26 | First Opinion Corporation | Disease management system |
US6270455B1 (en) * | 1997-03-28 | 2001-08-07 | Health Hero Network, Inc. | Networked system for interactive communications and remote monitoring of drug delivery |
US6558351B1 (en) * | 1999-06-03 | 2003-05-06 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
US5997475A (en) * | 1997-08-18 | 1999-12-07 | Solefound, Inc. | Device for diabetes management |
AU1371199A (en) * | 1997-10-31 | 1999-05-24 | Mercury Diagnostics Inc. | Analyte concentration information collection and communication s ystem |
US6144922A (en) * | 1997-10-31 | 2000-11-07 | Mercury Diagnostics, Incorporated | Analyte concentration information collection and communication system |
US6049764A (en) * | 1997-11-12 | 2000-04-11 | City Of Hope | Method and system for real-time control of analytical and diagnostic instruments |
US6579231B1 (en) * | 1998-03-27 | 2003-06-17 | Mci Communications Corporation | Personal medical monitoring unit and system |
US6081786A (en) * | 1998-04-03 | 2000-06-27 | Triangle Pharmaceuticals, Inc. | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens |
US8974386B2 (en) * | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
AU5218599A (en) * | 1998-07-20 | 2000-02-07 | Smithkline Beecham Corporation | Method and system for identifying at risk patients diagnosed with diabetes |
US6338713B1 (en) * | 1998-08-18 | 2002-01-15 | Aspect Medical Systems, Inc. | System and method for facilitating clinical decision making |
US6554798B1 (en) * | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
US6540672B1 (en) * | 1998-12-09 | 2003-04-01 | Novo Nordisk A/S | Medical system and a method of controlling the system for use by a patient for medical self treatment |
KR100627990B1 (ko) * | 1998-11-30 | 2006-09-26 | 노보 노르디스크 에이/에스 | 복수의 조치를 포함하는 의학적 자가 치료에서 사용자를돕기 위한 방법 및 시스템 |
JP2002538457A (ja) * | 1999-03-03 | 2002-11-12 | サイラノ・サイエンスィズ・インコーポレーテッド | 知覚データを検出しコンピュータネットワークで伝送する装置、システム、および方法 |
AU3632800A (en) * | 1999-03-29 | 2000-10-16 | Avocet Medical, Inc. | Meter with integrated database and simplified telemedicine capability |
US6336900B1 (en) * | 1999-04-12 | 2002-01-08 | Agilent Technologies, Inc. | Home hub for reporting patient health parameters |
US6390986B1 (en) * | 1999-05-27 | 2002-05-21 | Rutgers, The State University Of New Jersey | Classification of heart rate variability patterns in diabetics using cepstral analysis |
US6277071B1 (en) * | 1999-06-25 | 2001-08-21 | Delphi Health Systems, Inc. | Chronic disease monitor |
US6406426B1 (en) * | 1999-11-03 | 2002-06-18 | Criticare Systems | Medical monitoring and alert system for use with therapeutic devices |
US6418346B1 (en) * | 1999-12-14 | 2002-07-09 | Medtronic, Inc. | Apparatus and method for remote therapy and diagnosis in medical devices via interface systems |
ATE502567T1 (de) * | 2000-05-19 | 2011-04-15 | Welch Allyn Protocol Inc | Vorrichtung zur überwachung von patienten |
CA2689656A1 (en) * | 2000-06-16 | 2001-12-16 | Bayer Healthcare Llc | System, method and biosensor apparatus for data communications with a personal data assistant |
LV12612B (lv) * | 2000-08-21 | 2001-03-20 | Jehezkelis FINKELŠTEINS | Medicīniski-bioloģiskas informācijas vākšanas un apstrādes metode un sistēma |
BR8002322U (pt) * | 2000-10-16 | 2002-05-28 | Filtrona Brasileira Ind E Com | Recipiente armazenador e aplicador de desodorante lìquido |
US6450956B1 (en) * | 2000-11-06 | 2002-09-17 | Siemens Corporate Research, Inc. | System and method for treatment and outcome measurement analysis |
US6524240B1 (en) * | 2000-11-22 | 2003-02-25 | Medwave, Inc. | Docking station for portable medical devices |
US6645142B2 (en) * | 2000-12-01 | 2003-11-11 | Optiscan Biomedical Corporation | Glucose monitoring instrument having network connectivity |
US6799149B2 (en) * | 2000-12-29 | 2004-09-28 | Medtronic, Inc. | Therapy management techniques for an implantable medical device |
US6544212B2 (en) * | 2001-07-31 | 2003-04-08 | Roche Diagnostics Corporation | Diabetes management system |
US6781522B2 (en) * | 2001-08-22 | 2004-08-24 | Kivalo, Inc. | Portable storage case for housing a medical monitoring device and an associated method for communicating therewith |
US20030216628A1 (en) * | 2002-01-28 | 2003-11-20 | Bortz Jonathan David | Methods and systems for assessing glycemic control using predetermined pattern label analysis of blood glucose readings |
JP4289869B2 (ja) * | 2002-11-06 | 2009-07-01 | シスメックス株式会社 | 糖尿病診断支援システム |
US20050159656A1 (en) * | 2003-03-07 | 2005-07-21 | Hockersmith Linda J. | Method and apparatus for presentation of noninvasive glucose concentration information |
US20050187789A1 (en) * | 2004-02-25 | 2005-08-25 | Cardiac Pacemakers, Inc. | Advanced patient and medication therapy management system and method |
US20050267780A1 (en) | 2004-06-01 | 2005-12-01 | Pinaki Ray | Methods and systems of automating medical device data management |
CA3090413C (en) * | 2004-06-04 | 2023-10-10 | Abbott Diabetes Care Inc. | Glucose monitoring and graphical representations in a data management system |
US20060173260A1 (en) * | 2005-01-31 | 2006-08-03 | Gmms Ltd | System, device and method for diabetes treatment and monitoring |
US7509156B2 (en) * | 2005-05-18 | 2009-03-24 | Clarian Health Partners, Inc. | System for managing glucose levels in patients with diabetes or hyperglycemia |
US20080071580A1 (en) * | 2005-06-03 | 2008-03-20 | Marcus Alan O | System and method for medical evaluation and monitoring |
US20070033074A1 (en) * | 2005-06-03 | 2007-02-08 | Medtronic Minimed, Inc. | Therapy management system |
US20070016449A1 (en) * | 2005-06-29 | 2007-01-18 | Gary Cohen | Flexible glucose analysis using varying time report deltas and configurable glucose target ranges |
US20080235053A1 (en) * | 2007-03-20 | 2008-09-25 | Pinaki Ray | Communication medium for diabetes management |
US8758245B2 (en) * | 2007-03-20 | 2014-06-24 | Lifescan, Inc. | Systems and methods for pattern recognition in diabetes management |
-
2007
- 2007-03-20 US US11/688,743 patent/US20080234943A1/en not_active Abandoned
-
2008
- 2008-03-12 JP JP2008063000A patent/JP5179906B2/ja active Active
- 2008-03-20 CA CA002627385A patent/CA2627385A1/en not_active Abandoned
- 2008-03-20 EP EP08251030A patent/EP1988482A3/en not_active Withdrawn
- 2008-03-20 CN CNA2008101258725A patent/CN101308528A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002132952A (ja) * | 2000-04-28 | 2002-05-10 | Bryan K Chan | 慢性病と健康のオンラインを管理する方法及びシステム |
JP2004154547A (ja) * | 2002-06-05 | 2004-06-03 | Diabetes Diagnostics Inc | 特定成分検査装置、データ格納方法およびデータ処理方法 |
JP2004024699A (ja) * | 2002-06-27 | 2004-01-29 | Asahi Medical Co Ltd | 血糖管理システム、血糖管理プログラム、装着システムおよび血糖管理方法 |
WO2005093629A2 (en) * | 2004-03-26 | 2005-10-06 | Novo Nordisk A/S | Device for displaying data relevant for a diabetic patient |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8974385B2 (en) | 2009-09-23 | 2015-03-10 | Samsung Electronics Co., Ltd. | Method and apparatus for providing blood glucose management information |
US9563743B2 (en) | 2010-02-25 | 2017-02-07 | Lifescan Scotland Limited | Analyte testing method and system with high and low blood glucose trends notification |
JP2013520278A (ja) * | 2010-02-25 | 2013-06-06 | ライフスキャン・スコットランド・リミテッド | 高血糖及び低血糖傾向を通知する分析物試験方法及びシステム |
JP2013533783A (ja) * | 2010-06-30 | 2013-08-29 | ライフスキャン・スコットランド・リミテッド | 平均の食事前と食事後のグルコース差のメッセージ表示について統計的検出力を確実にするための方法、システム、及び装置 |
JP2019509085A (ja) * | 2016-02-05 | 2019-04-04 | アニマス・コーポレイション | 薬物送達システムのための可視化及び解析ツール |
JP6999648B2 (ja) | 2016-08-17 | 2022-01-18 | ノボ・ノルデイスク・エー/エス | インスリン投薬計画における基礎/ボーラス比を調節するためのシステムおよび方法 |
JP2019532391A (ja) * | 2016-08-17 | 2019-11-07 | ノボ・ノルデイスク・エー/エス | インスリン投薬計画における基礎/ボーラス比を調節するためのシステムおよび方法 |
US11462313B2 (en) | 2016-08-17 | 2022-10-04 | Novo Nordisk A/S | Systems and methods for adjusting a basal/bolus ratio in an insulin regimen |
JP2020507397A (ja) * | 2017-02-14 | 2020-03-12 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | 体液中のグルコースレベルを示すグルコースモニタリングデータを分析するための、コンピュータにより実施される方法および携帯型装置、ならびにコンピュータプログラム製品 |
JP7113833B2 (ja) | 2017-02-14 | 2022-08-05 | エフ ホフマン-ラ ロッシュ アクチェン ゲゼルシャフト | 体液中のグルコースレベルを示すグルコースモニタリングデータを分析するための、コンピュータにより実施される方法および携帯型装置、ならびにコンピュータプログラム製品 |
WO2020111109A1 (ja) * | 2018-11-27 | 2020-06-04 | 国立研究開発法人理化学研究所 | 状態可視化装置、状態可視化方法および状態可視化プログラム |
JP7445309B2 (ja) | 2018-11-27 | 2024-03-07 | 国立研究開発法人理化学研究所 | 状態可視化装置、状態可視化方法および状態可視化プログラム |
US11961204B2 (en) | 2018-11-27 | 2024-04-16 | Riken | State visualization device, state visualization method, and state visualization program |
Also Published As
Publication number | Publication date |
---|---|
CN101308528A (zh) | 2008-11-19 |
CA2627385A1 (en) | 2008-09-20 |
JP5179906B2 (ja) | 2013-04-10 |
EP1988482A2 (en) | 2008-11-05 |
EP1988482A3 (en) | 2009-03-18 |
US20080234943A1 (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5179906B2 (ja) | 糖尿病の管理用プログラム | |
JP5265946B2 (ja) | 血糖症管理用の伝達媒体 | |
JP5456981B2 (ja) | 糖尿病管理におけるパターン認識方法 | |
US20090240127A1 (en) | Methods of determining pre or post meal time slots or intervals in diabetes management | |
US9402956B2 (en) | Handheld diabetes manager with a user interface for displaying a status of an external medical device | |
JP6759201B2 (ja) | 慢性疾患の発見および管理システム | |
AU2013369674A1 (en) | Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance | |
WO2013006044A1 (en) | Patient mobile computing system and method for exacerbation prediction | |
Brown et al. | Can we use the Omron T9P automated blood pressure monitor in pregnancy? | |
Crespo et al. | Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk | |
CN113658704A (zh) | 糖尿病风险预测设备、装置和存储介质 | |
Li et al. | Using a partially observable Markov chain model to assess colonoscopy screening strategies–A cohort study | |
Plebani | Evaluating laboratory diagnostic tests and translational research | |
Read et al. | Measuring the association between body mass index and all-cause mortality in the presence of missing data: analyses from the Scottish National Diabetes Register | |
US11864888B2 (en) | User-defined structured testing for use in diabetes care | |
Malbora et al. | Ambulatory blood pressure monitoring of healthy schoolchildren with a family history of hypertension | |
Richesson et al. | Patient registries | |
TW201827013A (zh) | 生理參數監測系統 | |
RU2681196C2 (ru) | Способ и система поддержки принятия решений при удаленном мониторинге людей, входящих в группу онкологического риска | |
HE | Essays on predictive and prescriptive analytics for risk monitoring and population screening in healthcare management | |
Wechsler et al. | A model for setting optimal data-acquisition policy and its application with clinical data | |
Gutierrez et al. | Investigating the HbA1c Assessment Methods for a Smart and Connected Diabetes System | |
Hariprasad | Comparison of Acute Phyiology and Chronic Health Assessment II Score And Sequential Organ Failure Assessment Score to Predict Outcome in ICU Patients | |
CN117982135A (zh) | 生理参数监测系统 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110203 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120829 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120904 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121204 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121225 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130110 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5179906 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |